Bill Would Require Device Sponsors To Stratify PMA Trial Data By Gender
This article was originally published in The Gray Sheet
Executive Summary
Cardiovascular device manufacturers would be required to stratify clinical trial information for PMA submissions by gender, race and ethnicity under the "HEART for Women Act" (S 2278)
You may also be interested in...
ADVANCENT National Registry Reveals Gender Gap In ICD Therapy
The ongoing ADVANCENT national heart failure registry reveals that men indicated for an ICD are almost twice as likely to receive the device as women
Carotid Artery Disease Screening Should Make AHRQ Research List – Guidant
Guidant is requesting the Agency for Healthcare Research & Quality to assign the study of female cardiovascular care quality to a list of CMS research priorities to be generated under the Medicare Modernization Act
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.